BD Hypodermic Syringe 10 ml — Class II medical device recall Z-1109-2021
Terminated recall by Becton Dickinson & Company, reported 2021-02-24, distributed nationwide. The product packaging for the 10 ml eccentric tip syringe may exhibit open seals. An open seal impacts package
| Recall number | Z-1109-2021 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Becton Dickinson & Company, Franklin Lakes, NJ, United States |
| Recall initiated | 2020-12-23 |
| Classified | 2021-02-12 |
| Reported by FDA | 2021-02-24 |
| Terminated | 2022-11-21 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA |
| Quantity | 155,200 needles |
| Reason classes | sterility, packaging |
| UPC / GTIN / UDI-DI | 00382903054824 |
| Lot numbers | 8142303 |
| Model numbers | 00382903054824, 100/PACKAGE, 305482, 8142303BD |
| Expiration dates | 2023-05-31 |
Product
BD Hypodermic Syringe 10 ml, eccentric tip. Catalog (Ref No.) 305482
Reason for recall
The product packaging for the 10 ml eccentric tip syringe may exhibit open seals. An open seal impacts package integrity and potentially compromises sterility of the syringe.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1109-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.